On July 1, 2021 Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC, OTC: ENSCW) reported that the Company will begin trading its common stock under the ticker symbol "ENSC" on The Nasdaq Capital Market and warrants under the ticker symbol "ENSCW" on the OTC Market on July 2, 2021 (Press release, Ensysce Biosciences, JUL 1, 2021, View Source [SID1234585502]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

As previously announced, the Company closed its merger with Leisure Acquisition Corp. ("LACQ") on June 30, 2021, which was approved by LACQ’s shareholders on June 28, 2021.